These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8104078)

  • 1. Growth Disorders and GH Releasing Peptides. Evaluation of GH THerapy in Children and Adults. GH, Neoplasia and the Immune System. Proceedings of Novo Nordisk Workshop on Growth No.5. Denmark, September 24-26, 1992.
    J Pediatr Endocrinol; 1993; 6(1):1-111. PubMed ID: 8104078
    [No Abstract]   [Full Text] [Related]  

  • 2. Novo Nordisk Workshop on Growth No. 6. Proceedings. Denmark, October 1-2, 1993.
    J Pediatr Endocrinol; 1994; 7(2):79-180. PubMed ID: 7914800
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical actions of growth hormone.
    Wilson DM
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):519-37. PubMed ID: 1521510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy.
    Cella SG; De Gennaro Colonna V; Locatelli V; Bestetti GE; Rossi GL; Torsello A; Wehrenberg WB; Müller EE
    Pediatr Res; 1994 Sep; 36(3):315-22. PubMed ID: 7808827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of GH-releasing hormone and biosynthetic GH in a group of children with growth hormone deficiency].
    Biscaldi I; Fiori A; Moretta A; Valtorta A
    Medicina (Firenze); 1990; 10(2):145-6. PubMed ID: 2273946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment and cancer risk.
    Banerjee I; Clayton PE
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):247-63. PubMed ID: 17336744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the 13th Novo Nordisk Symposium on Growth Hormone and Endocrinology and of the SGA/IUGR Satellite Symposium. Budapest, Hungary, April 11-13, 2002.
    Horm Res; 2003; 59 Suppl 1():1-143. PubMed ID: 14598836
    [No Abstract]   [Full Text] [Related]  

  • 8. Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness.
    Bozzola M; Biscaldi I; Cisternino M; Severi F; Balsamo A; Cacciari E; Pellini C; Chiumello G; Spadoni GL; Boscherini B
    J Endocrinol Invest; 1990 Mar; 13(3):235-9. PubMed ID: 2195098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic treatment with biosynthetic growth hormone (GH) on the GH response to double GH-releasing hormone administration in children with short stature.
    Scacchi M; Danesi L; Pincelli AI; Dubini A; Cavagnini F
    J Endocrinol Invest; 1997 Feb; 20(2):72-6. PubMed ID: 9125486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and its disorders.
    Ayuk J; Sheppard MC
    Postgrad Med J; 2006 Jan; 82(963):24-30. PubMed ID: 16397076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current developments in the treatment of growth delay using growth hormone].
    Wit JM
    Tijdschr Kindergeneeskd; 1986 Dec; 54(6):170-6. PubMed ID: 3103256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to a bolus injection of 1-44 growth-hormone-releasing hormone in very short children with intrauterine onset of growth failure.
    Job JC; Chatelain P; Rochiccioli P; Ponte C; Olivier M; Sagnard L
    Horm Res; 1990; 33(5):161-5. PubMed ID: 2272607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing growth hormone therapy during puberty.
    Codner E; Mericq V; Cassorla F
    Horm Res; 1997; 48 Suppl 5():16-20. PubMed ID: 9434040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocytic nevi in children treated with growth hormone.
    Wyatt D
    Pediatrics; 1999 Oct; 104(4 Pt 2):1045-50. PubMed ID: 10506263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological and clinical studies of GRF and GH.
    Thorner MO; Vance ML; Evans WS; Blizzard RM; Rogol AD; Ho K; Leong DA; Borges JL; Cronin MJ; MacLeod RM
    Recent Prog Horm Res; 1986; 42():589-640. PubMed ID: 3090660
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone therapy in short stature.
    Knudtzon J; Aarskog D
    Pediatrician; 1987; 14(3):172-7. PubMed ID: 3331011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.